Search results
Roche To Ride Booming Obesity Treatment Market With Newly-Acquired Drug Candidate. Thursday, Genentech, a unit of Roche Holdings AG (OTC:RHHBY), released results from the Phase 1b trial of CT-388 ...
See Roche Holding AG (RHHBY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Feb 26, 2024 · Roche faces challenges with its pipeline and acquisitions but remains confident in its future growth prospects. Learn why RHHBY stock is a Buy.
Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales. In depth view into RHHBY (Roche) stock including the latest price, news, dividend history, earnings information and financials.
The latest Roche stock prices, stock quotes, news, and RHHBY history to help you invest and trade smarter. Menu icon A vertical stack of three evenly spaced horizontal lines.
Feb 11, 2024 · Despite recent challenges, Roche's 2024 guidance shows potential for mid-single digit growth in revenues and EPS. Find out why RHHBY stock is a Buy.
Track Roche Holdings AG ADR (RHHBY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors
